News

Dec 2018   The AABB Annual Meeting Highlights Conference and Exhibition in the Middle East 2019 will be held 25-26 January 2019 in Abu Dhabi, United Arab Emirates. This meeting once again brings highlights from the 2018 AABB Annual Meeting directly to professionals from across the Middle East, Africa and Asia.

Dec 2018   StemCyte is expanding their cord blood donation program at a time when most public banks are closing collection centers. StemCyte’s California laboratory is one of a handful around the world that is accredited by both AABB and FACT.  World-wide, StemCyte has provided over 2200 cord blood units to over 350 transplant centers, to treat over 58 conditions in 38 countries.

Dec 2018   Vitalant is the new brand name for all 10 of the blood centers owned by Blood Systems. As part of the reorganization under the Vitalant brand, the public cord blood bank at Community Blood Services (now Vitalant New Jersey) has taken over the cord blood operations of the Institute of Transfusion Medicine (ITxM) in Chicago.

Dec 2018   "It is incumbent on the medical institutions that delivered babies with immediate cord clamping to review their records and attempt to evaluate any long term health impact for those infant donors". Dr. Norman Ende, pioneer in the development of cord blood therapy, believes that infants who received more cord blood at birth have greater protection against medical problems later in life. This has never been tested in retrospective studies. He calls for medical institutions to test this hypothesis by reviewing their records, identifying these donors, and tracking them down to learn their health histories.

Nov 2018   Due to consolidation in the ownership of family cord blood banks, the world's top 10 companies manage more than 60% of privately stored newborn stem cells.

Nov 2018   The 5th Annual Congress of the Perinatal Stem Cell Society is taking place February 28th and March 1st 2019 at the Leonardo Museum in Salt Lake City, Utah. For more information about the congress please visit the website of the Perinatal Stem Cell Society.

Nov 2018   The choice of growth medium formulation is critical to MSC expansion because it impacts the staility of the process as well as the potency of the final product. Within cellular Good Manufacturing Practices (cGMP) there are multiple options allowed, including fetal bovine serum (FBS), human serum (hS), human platelet lysate (hPL), as well as options that are xenofree (XF) and/or serum-free (SF).

Oct 2018   FamiCord Group is a network of cord blood banks and marketing partners that offers family storage across Europe and has inventory of 355,000, the largest in Europe. The head of FamiCord Group is the bank PBKM in Poland. PBKM has provided therapy with MSC from umbilical cord tissue to over 1,000 patients with a variety of diagnoses, and is launching 7 late-phase trials that will treat another 700 patients. PBKM is the leading provider of MSC manufactured from umbilical cord tissue in the entire western hemisphere.

Oct 2018   "After going through all that we have lived, a new world opens up for me. Today to conserve the Stem Cells is something that I would recommend with my eyes closed. What seemed like a science fiction movie is what will allow me to see Matías grow".

Oct 2018   In stirred tank bioreactors, “microcarriers” provide the surface where the adherent cells will attach and grow. Microcarriers are small beads with diameters between 100 and 250 µm. Microcarriers can be porous or non-porous, positively charged or non-charged, may or may not be xeno-free, and some microcarriers are biodegradable. The choice of microcarrier is key to the success of MSC growth in stirred tank bioreactors, because the attachment phase between MSC and microcarriers is critical for the success of the expansion process.